Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

3 Penny Stocks That Can Quadruple by 2025

These are the penny stocks with 4x potential by 2025, for investors seeking businesses with a sound business models.

7 Stocks to Buy for This ‘Washing Machine’ Market

Do you know what a “washing machine” market looks like? If not, look around – because you’re in one now. Here's how you can take advantage.

3 Penny Stocks to Make You the Millionaire Next Door

Explore the world of high-risk, high-reward top penny stocks to buy and uncover promising investment opportunities.

3 Biotech Stocks With Blockbuster Potential

Although risky, these biotech stocks with blockbuster potential may skyrocket should regulatory winds favor their therapeutics.

5 Investors Betting Big on Ocugen (OCGN) Stock Right Now

Ocugen has been falling after announcing a new share offering. But that's not the only reason hedge funds are moving away from OCGN stock.

Why Is Apexigen (APGN) Stock Up 31% Today?

Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS).

Why Is Ocugen (OCGN) Stock Down 22% Today?

Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares.

Why Is PTC Therapeutics (PTCT) Stock Down 21% Today?

PTC Therapeutics (PTCT) stock is taking a beating on Wednesday after the company provided investors with an update on a clinical trial.

Why Is Minerva Surgical (UTRS) Stock Up 229% Today?

Minerva Surgical (UTRS) stock is rising Wednesday despite a lack of news from the surgical and medical instrument manufacturing company.

3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024 

These biotech stocks with high return potential are poised to provide quick returns for investors who invest over the next year.

Why Is Ocean Biomedical (OCEA) Stock Up 28% Today?

Ocean Biomedical received a critical patent covering multiple cancers, sending OCEA stock higher on frenzied trading as a result.

3 Undervalued Penny Stocks to Buy for Multi-Bagger Returns

Are you after some great high-risk, high-return bargains? This article delves deep into high return penny stocks you can buy now.

Why Is CohBar (CWBR) Stock Up 130% Today?

CohBar (CWBR) stock is soaring higher on Tuesday after the company announced a planned a;;-stock merger with Morphogenesis.

3 Biotech Stocks to Avoid Like the Plague

Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs.

3 High-Yield ETFs to Buy for Massive Income Potential

Despite higher interest rates, these three high dividend yield ETFs will deliver income and capital appreciation without too much risk.

Why is Mallinckrodt (MNK) Stock Down 27% Today?

Mallinckrodt (MNK) stock is falling on Monday with strong trading despite a lack of news concerning the pharmaceutical company.

The 3 Best Momentum Stocks to Buy in May 2023

These momentum stocks have certainly picked up the pace in recent months, and I think this could continue in May and beyond.

Why Is SeqLL (SQL) Stock Up 43% Today?

SeqLL (SQL) stock is on the rise Monday with heavy trading despite a lack of news from the molecule sequencing technology company.

Why Is Hepion Pharmaceuticals (HEPA) Stock Up 68% Today?

Hepion Pharmaceuticals (HEPA) stock is rising higher on Monday as the company prepares to cover clinical trial results this morning.